Notice

As a result of the current Federal government funding situation, the information on this website may not be up to date or acted upon.  

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at https://www.opm.gov/.

Emily Boja, Ph.D.

Program Director

Emily Boja

Dr. Boja provides leadership in managing scientific portfolio of the CPTAC program involving complex proteogenomic analyses of proteins and post-translational modifications in biological and clinical samples to ensure scientific and programmatic goals are met. She also oversees the analytical and regulatory aspects of molecular diagnostics technologies and platforms via interactions with the U.S. Food and Drug Administration (FDA) and the American Association of Clinical Chemistry (AACC).  Prior to the National Cancer Institute, Dr. Boja served as a Staff Scientist and Lead of Proteomics at the Laboratory of Cardiac Energetics and the Laboratory of Biophysical Chemistry, National Heart, Lung and BIood Institute, NIH.  Her expertise originates from her research on structural / functional studies of key enzymes and pathways involved in one-carbon metabolism critical for energy metabolism in many diseases including cancer, and later proteomic analyses of complex systems via the integration of genomics and proteomics data, and models of systems biology.  Dr. Boja holds a Ph.D. degree in Biochemistry and Molecular Biology (1999) from the Medical College of Virginia, Virginia Commonwealth University.